What we do: Pharmaceutical Consulting, Strategic Consulting, Pharmaceutical Strategic Consulting Strategic Opportunity Assessment – Diagnostic process for continuously improving project managements performances. Clinical site; KOL Evaluation in Asia – Development of clinical sites and evaluation of KOL treatment algorithms Compliant manufacturing Site Proposal – Forecasting optimal asset allocation to achieve compliant manufacturing.

1. Pharma Consulting | Strategic Consulting

2. Pharmaceutical Consulting
About Us
We are Razrbiopharm (www.razrbiopharm.com) an offshore company with offices in New Jersey,
USA and Bangalore, India that provides strategic consulting services to executives in the
Pharmaceutical and Biotech Industries.
Our primary focus is:
•
•
•
•
•
•
•
Strategic Marketing Analytics
Market evaluation for new markets, indications etc.
Opportunity Assessments and Sales forecasting
Strategic Evaluation of Business Development and licensing deals
Primary & Secondary Market Research
Clinical trial site identification in Asia (specifically India)
The firm is managed by individuals experienced in Drug Development, Strategic Marketing and
Finance and can be contacted at:
USA:
PJ Lavsi-CEO
pjlavsi@razrbiopharma.com
Ph: 908-328-5518
India:
Ram Narayan-Chairman
ramnarayan@razrbiopharma.com
Ph: +91-9844012534

3. Pharmaceutical Consulting
Value Proposition - Quality & Innovation at a Lower Cost
High-Quality analytics and innovative solutions driven by:
•
•
•
Custom research evaluation in healthcare industry with rapid turnaround times
Industry experience (US, Europe & Asia) and therapeutic knowledge of founders
& team members
Work-culture conducive to new idea generation and innovative thinking and high
quality research
Compelling Cost and Time and Extension of Resources Advantages
•
•
Reduced fixed costs through outsourcing
Reduced down time for client because of time zone advantage

4. Pharmaceutical Consulting
Key Offerings
Business Intelligence and Analysis
•
•
•
•
•
•
New Product and Technology Assessment
Revenue Forecasting and Asset Valuation
Competitive Intelligence
Performance Measurement and Decision Analysis
Cost and Treatment Analysis
Market Evaluation-Regional & Global
Project Management Services
•
•
•
Strategic Opportunity Assessments and Market Entry Strategies
Benchmarking
Clinical Site and KOL Evaluation In Asia

5. Pharmaceutical Consulting
Business Intelligence and Analysis – Key Offerings
Services Offered and Description
Forecasting and Asset
Valuation

Product/market forecasting, asset valuation and licensing , deal
structuring services.
Competitive
Intelligence

Gathering primary and secondary competitive intelligence and
quantifying impact on product. Market Evaluation
Patient Flow and Cost
Analysis

Determining patient treatment flow and modeling cost of
treatment.
Performance
Measurement

Producing routine monthly/quarterly sales, market and competitive
intelligence reports.

6. Pharmaceutical Consulting
Project Management Services – Key Offerings
Services Offered and Description
Strategic Opportunity
Assessment

Evaluation, Strategic options, benchmarking and planning.
Clinical Site & KOL
Evaluation in Asia

Development of clinical sites and evaluation of KOL treatment
algorithms
Compliant
Manufacturing Site
Proposal

Forecasting optimal asset allocation to achieve compliant
manufacturing.

7. Pharmaceutical Consulting
Experienced Leaders
Ram Narayan B.Sc., M.Sc.,PhD. Pharm.(Bel.)
Broad range of experience in pharmaceutical industry in marketing and business
development for over 20 years
Premal Lavsi B.Com, A.C.A., CPA
Over 25 years of experience in marketing and finance with Global pharmaceutical
companies like Bristol-Myers Squibb, Hoechst and Sanofi- Aventis. Experienced in
strategic planning, new product development, business strategy and
commercialization

8. Pharmaceutical Consulting
The In-House Team
•
•
•
•
Business Analysts (2) – B.Pharm/MBA; domain experts.
Market Research Expert (1) – MS Statistics, Market Research Experience
Statistician (1) – Ph.D. Statistics
Software Developers (2) – B.S./ M.S.; software development both web-based and stand-alone
Advisors
H. Badri MD, MBBS
Medical Advisor Novo Nordisk India
Chief Medical Advisor Anglo French India
Involved in phase III trials in critical bleeds of Novo 7
A K Goel
Vice President Carewell Technologies and Products
Senior Director SKF Pharma India
Involved in phase III trials of cimitidine
PhD Oxford

9. Pharmaceutical Consulting
Razr’s Case Studies
•
Completed an evaluation of basic research companies in the Indian market
$500M+ company
•
Completed a review of target Oncology companies to evaluate acquisition
opportunities-$1b + Pharma co. & a mid size biotech company. Large specialty
pharma company
•
Completed a strategic review of the Global Oncology marketplace -$2B + Large
Pharma
•
Completed a review of Oncology distribution practices in the Indian market- Large
Japanese Company
•
Completed an opportunity assessment for a PG x test in obesity-Start-up
•
Completed a review of the bio-similar market in India-$500M + biologics company

10. Pharmaceutical Consulting
Why Razr Biopharm
•
Broad-based analytical capabilities both primary & secondary
strategic research
•
Broad-based experience of team & leaders-Science, Business
and Marketing
•
High-Quality Analytics Done Rapidly
•
Potential for significant cost savings

11. Contact Today
RazrBiopharm
OR
Call: 91-908-328-5518